Fig. 10From: Management of retinitis pigmentosa by Wharton’s jelly derived mesenchymal stem cells: preliminary clinical resultsReleasing of epiretinal membrane contraction after the WJ-MSC application (Table 1, patient no.26: left eye)Back to article page